BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11730053)

  • 1. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 3. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
    Khalid M; Mujtaba G; Haroon TS
    Int J Dermatol; 1995 Mar; 34(3):203-5. PubMed ID: 7751099
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's new in the treatment of vitiligo.
    Falabella R
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):287-9. PubMed ID: 11730030
    [No Abstract]   [Full Text] [Related]  

  • 7. Reproducible elevation of liver transaminases by topical 8-methoxypsoralen.
    Park YM; Kim TY; Kim HO; Kim CW
    Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):261-3. PubMed ID: 7727284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo.
    Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo therapy: where are we now?
    Arroyo MP; Tift L
    J Drugs Dermatol; 2003 Aug; 2(4):404-8. PubMed ID: 12884463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitiligo with oral methoxsalen and UVA.
    Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
    Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs. 8-methoxypsoralen gel-PUVA.
    Grundmann-Kollmann M; Leiter U; Behrens S; Gottlöber P; Mooser G; Krähn G; Kerscher M
    Br J Dermatol; 1999 May; 140(5):988-90. PubMed ID: 10354061
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukoderma punctata following topical PUVAsol treatment.
    Fernandes NC; Pina JC
    An Bras Dermatol; 2010; 85(4):571-2. PubMed ID: 20944925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vitiligo with oral 5-methoxypsoralen.
    Hann SK; Cho MY; Im S; Park YK
    J Dermatol; 1991 Jun; 18(6):324-9. PubMed ID: 1939861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoralen phototherapy and phototoxicity.
    Berakha GJ; Lefkovits G
    Ann Plast Surg; 1985 May; 14(5):458-61. PubMed ID: 4083703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
    Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of vitiligo].
    Frenk E
    Hautarzt; 1986 Jan; 37(1):1-5. PubMed ID: 3949507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUVA therapy.
    Helm TN; Dijkstra JW; Ferrara RJ; Glanz S
    Am Fam Physician; 1991 Mar; 43(3):908-12. PubMed ID: 2000735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo.
    Godse KV
    Indian J Dermatol Venereol Leprol; 2008; 74(3):298. PubMed ID: 18597981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.